Common use of No Third Party Patents Clause in Contracts

No Third Party Patents. Except as disclosed in writing by VERTEX to NOVARTIS or its agents, to VERTEX's knowledge and based on its current understanding of the Drug Product Candidate(s) and its use, the development, manufacture, use or sale of any Bulk Drug Substance, Drug Product Candidates or Drug Products pursuant to this Agreement will not infringe or conflict with any Third Party right or patent, and VERTEX is not aware of any issued patent or pending patent application that, if issued, would be infringed by the development, manufacture, use or sale of any Bulk Drug Substance, Drug Product Candidates or Drug Products pursuant to this Agreement.

No Third Party Patents. Except as disclosed in writing by NOVARTIS to VERTEX to NOVARTIS or its agents, to VERTEX's NOVARTIS' knowledge and based on its current understanding of the Drug Product Candidate(s) and its use, the development, manufacture, use or sale of any Bulk Drug Substance, Drug Product Candidates or Drug Products pursuant to this Agreement will not infringe or conflict with any Third Party right or patent, and VERTEX NOVARTIS is not aware of any issued patent or pending patent application that, if issued, would be infringed by the development, manufacture, use or sale of any Bulk Drug Substance, Drug Product Candidates or Drug Products pursuant to this Agreement.

No Third Party Patents. Except as disclosed in writing by VERTEX to NOVARTIS SCHERING or its agents, to VERTEX's knowledge and based on its current understanding of the Drug Product Candidate(s) and its use, the development, manufacture, use or sale of any Bulk Drug Substance, Drug Product Candidates or Drug Products pursuant to this Agreement will not infringe or conflict with any Third Party right or patent, and VERTEX is not aware of any issued patent or pending patent application that, if issued, would be infringed by the development, manufacture, use or sale of any Bulk Drug Substance, Drug Product Candidates or Drug Products pursuant to this Agreement.

No Third Party Patents. Except as disclosed in writing by VERTEX to NOVARTIS or its agentson SCHEDULE 9.1 hereof, to VERTEX's actual knowledge and based on its current understanding of the Drug Product Candidate(s) Compounds and its their use, the development, manufacture, use or sale of any Bulk Drug Substance, Drug Product Candidates or Drug Products Product pursuant to this Agreement will not infringe or conflict with any Third Party right or patentPatent, and VERTEX is not aware of any issued patent or pending patent application that, if issued, would be infringed by the development, manufacture, use or sale of any Bulk Drug Substance, Drug Product Candidates or Drug Products Product pursuant to this Agreement.